» Articles » PMID: 11481323

Molecular Cloning and Characterization of PELP1, a Novel Human Coregulator of Estrogen Receptor Alpha

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Aug 2
PMID 11481323
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear hormone receptors (NRs) are transcription factors whose activity is regulated by ligands and by coactivators or corepressors. We report the characterization of a new NR coregulator: proline-, glutamic acid-, leucine-rich protein 1 (PELP1), a novel human protein that comprises 1,282 amino acids and is localized on chromosome 17. The primary structure of PELP1 consists of several motifs present in most transcriptional regulators including nine NR-interacting boxes (LXXLL motifs), a zinc finger, and glutamic acid- and proline-rich regions. We demonstrate that PELP1 is a coactivator of estrogen receptor alpha (ERalpha). PELP1 enhances 17beta-estradiol-dependent transcriptional activation from the estrogen response element in a dose-dependent manner. PELP1 interacts with ERalpha and also with general transcriptional coactivators p300 and cAMP response element-binding protein-binding protein. PELP1 was differentially expressed in various human and murine tissues with the highest expression levels in the testes, mammary glands, and brain. We also provide evidence supporting the developmental regulation of PELP1 expression in murine mammary glands, the detectable expression of PELP1 in human mammary cancer cell lines, and the enhanced expression of PELP1 in human breast tumors. These findings suggest that PELP1 is a novel coregulator of ERalpha and may have a role in breast cancer tumorigenesis.

Citing Articles

PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma.

Nassar K, Yang X, Baker A, Gopalam R, Arnold W, Adeniran T Cancer Res Commun. 2024; 4(10):2610-2620.

PMID: 39258975 PMC: 11456993. DOI: 10.1158/2767-9764.CRC-24-0173.


PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.

Yang X, Liu Z, Tang W, Pratap U, Collier A, Altwegg K Mol Oncol. 2023; 18(9):2136-2156.

PMID: 37853941 PMC: 11467795. DOI: 10.1002/1878-0261.13539.


Expression of estrogen receptors, PELP1, and SRC in human spermatozoa and their associations with semen quality.

Skibinska I, Andrusiewicz M, Jendraszak M, Zbikowska A, Jedrzejczak P, Kotwicka M Hum Cell. 2022; 36(2):554-567.

PMID: 36577884 PMC: 9947025. DOI: 10.1007/s13577-022-00847-6.


Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold.

Gordon J, Chapus F, Viverette E, Williams J, Deterding L, Krahn J Nat Commun. 2022; 13(1):6783.

PMID: 36351913 PMC: 9646879. DOI: 10.1038/s41467-022-34610-0.


A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.

Altwegg K, Viswanadhapalli S, Mann M, Chakravarty D, Krishnan S, Liu Z Cancer Res. 2022; 82(20):3830-3844.

PMID: 35950923 PMC: 9588738. DOI: 10.1158/0008-5472.CAN-22-0698.